July 20 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL BIO LTD - COMMENCED IN VIVO (ANIMAL) STUDY FOR OUR COVID-19 VACCINE CANDIDATE
* VAXIL BIO LTD - FIRST ANIMAL INJECTION WAS ADMINISTERED ON JULY 14
* VAXIL BIO - HAS SUFFICIENT FUNDS TO COMPLETE COLLABORATION WORK WITH TEL AVIV MEDICAL CENTER
* VAXIL BIO LTD - IS ENTERING INTO A MEDIATION WITH A FORMER OFFICER OF CO IN CONNECTION WITH A DISAGREEMENT REGARDING COMPENSATION
* VAXIL BIO - SEEKS TO RAISE ADDITIONAL FUNDS TO PURSUE OTHER INNOVATIVE PROGRAMS IN ONCOLOGY AND INFECTIOUS DISEASES